Ocugen, Inc. (OCGN)
1.80
+0.07
(+4.05%)
USD |
NASDAQ |
May 01, 16:00
1.78
-0.02
(-1.11%)
After-Hours: 20:00
Ocugen EPS Diluted (Quarterly) : -0.0567 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | -1.298 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Krystal Biotech, Inc. | 1.699 |
| Phathom Pharmaceuticals, Inc. | -0.3701 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.71M |
| Revenue (Quarterly) | -0.193M |
| Total Expenses (Quarterly) | 17.51M |
| Enterprise Value | 623.91M |
| Earnings Yield | -12.54% |
| Normalized Earnings Yield | -12.54 |